Truvada News and Research

RSS
US health care providers reluctant to prescribe HIV prevention plan

US health care providers reluctant to prescribe HIV prevention plan

HIV Prevention Trials Network launches two phase 2 studies to evaluate new HIV drugs

HIV Prevention Trials Network launches two phase 2 studies to evaluate new HIV drugs

NIH-sponsored clinical trials examine safety, acceptability of HIV antiretroviral medicines

NIH-sponsored clinical trials examine safety, acceptability of HIV antiretroviral medicines

Dosing of antiretroviral medication to prevent HIV infection differs by sex

Dosing of antiretroviral medication to prevent HIV infection differs by sex

Viewpoints: Many beneficiaries of health law don't vote; reboot for healthcare.gov

Viewpoints: Many beneficiaries of health law don't vote; reboot for healthcare.gov

First Edition: August 12, 2014

First Edition: August 12, 2014

State highlights: Va. Lt. Gov.'s politics and pediatrics juggle; Md. hospital error reporting; ruling on Fla. 'Docs V. Glocks' law

State highlights: Va. Lt. Gov.'s politics and pediatrics juggle; Md. hospital error reporting; ruling on Fla. 'Docs V. Glocks' law

Longer looks: the economics of infertility; placebos as treatment raises ethical dilemmas

Longer looks: the economics of infertility; placebos as treatment raises ethical dilemmas

State highlights: Iowa invests in autism program; rural docs feel the pinch of Wisconsin's low Medicaid payments

State highlights: Iowa invests in autism program; rural docs feel the pinch of Wisconsin's low Medicaid payments

First Edition: July 14, 2014

First Edition: July 14, 2014

Viewpoints: Working for benefits; fears for a pill to prevent HIV; possible Medicaid strategy for Virginia

Viewpoints: Working for benefits; fears for a pill to prevent HIV; possible Medicaid strategy for Virginia

Viewpoints: Political stand-off on insurance industry safeguards; VA's problems may lie in how government works

Viewpoints: Political stand-off on insurance industry safeguards; VA's problems may lie in how government works

Women using DMPA injection more likely to acquire HIV than women using NET-EN

Women using DMPA injection more likely to acquire HIV than women using NET-EN

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Researchers launch phase II clinical trial of rectal microbicide to prevent HIV infections

Researchers launch phase II clinical trial of rectal microbicide to prevent HIV infections

Experts address ethical issues raised by FDA's approval of Truvada for HIV prevention

Experts address ethical issues raised by FDA's approval of Truvada for HIV prevention

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Reformulated version of anti-HIV gel safe for HIV-negative men and women

Reformulated version of anti-HIV gel safe for HIV-negative men and women

Women's low adherence to daily-dose products in HIV prevention trial suggest different approach needed, researchers say

Women's low adherence to daily-dose products in HIV prevention trial suggest different approach needed, researchers say

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective

Study finds antiretroviral-based strategies to prevent HIV infection among women prove ineffective